I don't see how this would work to boost the share price? If they're lying about this data it'll kill them as a company. They're announcing that the drug worke

I don't see how this would work to boost the share price? If they're lying about this data it'll kill them as a company. They're announcing that the drug worked in the trial that most people have been playing close attention to. That is a randomized controlled trial run by the NIH etc. They're not just saying positive results, they say in their press release that "We understand that the trial has met its primary endpoint and that NIAID will provide detailed information at an upcoming briefing" [0]. That's a clear statistical indication that the drug works. If they're lying about that, it'll kill their credibility and tank their stock. [0] https://www.gilead.com/news-and-press/press-room/press-releases/2020/4/gilead-sciences-statement-on-positive-data-emerging-from-national-institute-of-allergy-and-infectious-diseases-study-of-investigational-antiviral-rem https://www.gilead.com/news-and-press/press-room/press-relea...